Xebra Brands - XBRAF STOCK NEWS

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has completed all conditions to license its Solutech™ technology from New Age Nanotech. This patent-pending cannabinoid emulsion technology converts cannabis extracts into shelf-stable, water-soluble forms for beverages and edibles. Unique for its completion of a Phase-I human clinical trial, Solutech™ is poised for commercialization, starting with the launch of Vicious Citrus THC Lemonade in Canada in Spring 2022. Xebra holds exclusive rights for production in Mexico and Colombia and non-exclusive rights in Europe and the Americas.

Xebra Brands Ltd. (OTCQB: XBRAF) announced the granting of trademarks in the European Union for its THC and CBD-infused beverage brands, covering 28 countries and 10 territories. The trademarks include MADCAP soft drinks, HOLAHI iced teas, HIGHJACK energy drinks, VICIOUS CITRUS lemonades, and HIGHCASTLE waters, along with the CONQUER CBD sports drink. Xebra also holds a cannabis injunction from the Mexican Supreme Court, positioning it strongly in Mexico's CBD and CBG sectors. The company has plans to launch Vicious Citrus lemonade in Canada in spring 2022 and is evaluating cannabis seed varieties in Colombia.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has completed its 100% acquisition of Desart MX, issuing 48 million shares to Mexican vendors, held in escrow for 38 months. Desart secured an irrevocable injunction from the Mexican Supreme Court, giving it a first-mover advantage in the CBD and CBG market, allowing for low-THC cannabis cultivation. Xebra plans to secure land for cultivation and explore joint ventures with US and Canadian companies, aiming to leverage Mexico's position within the North American market.

Xebra Brands Ltd. (CSE: XBRA, OTC: XBRAF) has upgraded its listing to trade on the OTCQB Venture Markets as of January 10, 2022. This transition aims to enhance liquidity and provide a seamless trading experience for U.S. investors. The upgrade mandates greater transparency and reporting standards, including exemptions from U.S. state securities laws. Additionally, Xebra has submitted an application for DTC eligibility to FINRA.

Xebra Brands Ltd. (CSE: XBRA, OTC: XBRAF) has officially begun cannabis cultivation in the Netherlands, focusing on THC varietals. Selected as one of only five companies by the Dutch government for a medicinal cannabis cultivation trial, Xebra aims to secure one of two licenses that could yield revenues of up to US$79 million (€70.5 million) over a six-year contract. Cultivation occurs in an indoor facility with high-quality genetic varieties and a growth cycle of 12-16 weeks, led by industry expert Harry von Duijne.

Xebra Brands Ltd. (CSE: XBRA, OTC: XBRAF) announced significant media coverage following its December 2 injunction from the Mexican Supreme Court, granting it a first-mover advantage in the CBD and CBG market. Coverage includes interviews with Chairman Robert Giustra on outlets like CNN en ESPAÑOL and Reuters. Xebra anticipates this advantage could last 1 to 3 years, potentially disrupting the U.S. and Canadian markets. The Mexican cannabis consumer market is expected to be lucrative, with projected sales reaching USD $102 million by 2026.

Xebra Brands Ltd. announces significant progress in its Mexican operations through its subsidiary, Xebra Mexico, which has secured an irrevocable injunction from the Mexican Supreme Court. This grant provides Xebra with a first-mover advantage in the CBD and CBG market in Mexico, independent of the expected legalization of cannabis due in 2022. As Xebra plans to acquire up to 300 hectares for cultivation and explores partnerships with Canadian and American companies, it positions itself to capitalize on Mexico's potential as a major cannabis consumer market, benefiting from cost advantages in the North American trade zone.

Xebra Brands Ltd. (CSE: XBRA; OTC: XBRAF; FSE: 9YC), a cannabis company, announced it has secured trademarks in Mexico for several THC and CBD-infused beverage brands, including MADCAP, HIGHJACK, VICIOUS CITRUS, HIGHCASTLE, and CONQUER. President Rodrigo Gallardo highlighted this milestone as a key step toward capturing Mexico's emerging cannabis market. Additionally, Xebra anticipates a decision from the Mexican Supreme Court on December 1, which could enhance its position in the cannabis sector. The company is also vying for licenses in the Netherlands and progressing in Colombia.

Xebra Brands Ltd. (CSE: XBRA) (OTC: XBRAF) has started trading on the OTC Pink marketplace in the United States. The move aims to expand its market presence in the U.S., where OTC Markets handles over 11,500 securities with a trade volume exceeding US$500 billion year-to-date. Xebra is pursuing an upgrade to the OTCQB market and has applied for registration with the Depository Trust Company to facilitate electronic share settlement. Additionally, the company is entering a consulting agreement for investor relations services worth CA$30,000.